COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Forecast and Price Target with Analyst Ratings, Revenue Estimates, and complete financial and advanced discounted cashflow forecasts for up to 10 years.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

Analyst Consensus

Compare with Competitor

None

View analysts' price targets and recommendations, and compare them with competitors.

Analyst Price Target

No Data

No price target data available for this metric.

Analyst Recommendation

Neutral consensus among analysts.

Financial Forecasts for May 2029

Select Date

May 2030 May 2029 May 2028 May 2027 May 2026 May 2025

Compare with Competitor

None 3391.T 3141.T 3088.T

Analyze analyst forecasts for the company and compare them with competitors.

Estimated Revenue

1283.80B

Increased from previous period

Low: 1258.13B | High: 1308.45B

Better than 3391.T's estimated revenue of 1207.30B.

Estimated EBITDA

76.89B

Increased from previous period

Low: 75.35B | High: 78.37B

Better than 3391.T's estimated ebitda of 76.82B.

Estimated EPS

444.50

Decreased from previous period

Low: 432.95 | High: 455.60

Worse than 3391.T's estimated eps of 648.40.

Estimated Net Income

35.22B

Increased from previous period

Low: 34.31B | High: 36.10B

Better than 3391.T's estimated net income of 31.67B.

Estimated EBIT

51.10B

Decreased from previous period

Low: 50.08B | High: 52.09B

Worse than 3391.T's estimated ebit of 57.81B.

Estimated SG&A Expense

181.65B

Decreased from previous period

Low: 178.02B | High: 185.14B

Better than 3391.T's estimated sg&a expense of 298.89B.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2019

Select Year

2029 2028 2027 2026 2025 2024

Compare with Competitor

None 3391.T 3141.T 3088.T

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

684.40B

No peer data available for comparison.

Revenue Growth Rate

No Data

No DCF data available for this metric in the selected year.

EBITDA

42.66B

No peer data available for comparison.

EBITDA Margin

6.23%

No peer data available for comparison.

EBIT

29.09B

No peer data available for comparison.

EBIT Margin

4.25%

No peer data available for comparison.

Depreciation

13.56B

No peer data available for comparison.

Total Cash

52.12B

No peer data available for comparison.

Cash as Percentage of Revenue

7.62%

No peer data available for comparison.

Receivables

108.00M

No peer data available for comparison.

Receivables as Percentage of Revenue

0.02%

No peer data available for comparison.

Inventories

53.56B

No peer data available for comparison.

Inventories as Percentage of Revenue

7.83%

No peer data available for comparison.

Accounts Payable

136.53B

No peer data available for comparison.

Payables as Percentage of Revenue

19.95%

No peer data available for comparison.

Capital Expenditure

-25.95B

No peer data available for comparison.

CapEx as Percentage of Revenue

-3.79%

No peer data available for comparison.

Weighted Average Cost of Capital (WACC)

5.07%

No peer data available for comparison.

Cost of Equity

5.18%

No peer data available for comparison.

Cost of Debt

3.99%

No peer data available for comparison.

Beta

0.25

No peer data available for comparison.

Diluted Shares Outstanding

79.24M

No peer data available for comparison.

Total Debt

34.06B

No peer data available for comparison.

Total Equity

696.60B

No peer data available for comparison.

Total Capital

730.66B

No peer data available for comparison.

Debt Weighting

4.66%

No peer data available for comparison.

Equity Weighting

95.34%

No peer data available for comparison.

EBIAT

20.51B

No peer data available for comparison.

Unlevered Free Cash Flow

90.99B

No peer data available for comparison.

Long-Term Growth Rate

2.00%

No peer data available for comparison.

Terminal Value

379.47B

No peer data available for comparison.

Enterprise Value

352.81B

No peer data available for comparison.

Net Debt

-18.24B

No peer data available for comparison.

Equity Value

371.05B

No peer data available for comparison.

Equity Value Per Share

4682.65

No peer data available for comparison.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2019

Select Year

2029 2028 2027 2026 2025 2024

Compare with Competitor

None 3391.T 3141.T 3088.T

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

684.40B

No peer data available for comparison.

Revenue Growth Rate

No Data

No DCF data available for this metric in the selected year.

EBITDA

42.66B

No peer data available for comparison.

EBITDA Margin

6.23%

No peer data available for comparison.

EBIT

29.09B

No peer data available for comparison.

EBIT Margin

4.25%

No peer data available for comparison.

Depreciation

13.56B

No peer data available for comparison.

Total Cash

52.12B

No peer data available for comparison.

Cash as Percentage of Revenue

7.62%

No peer data available for comparison.

Receivables

108.00M

No peer data available for comparison.

Receivables as Percentage of Revenue

0.02%

No peer data available for comparison.

Inventories

53.56B

No peer data available for comparison.

Inventories as Percentage of Revenue

7.83%

No peer data available for comparison.

Accounts Payable

136.53B

No peer data available for comparison.

Payables as Percentage of Revenue

19.95%

No peer data available for comparison.

Capital Expenditure

-25.95B

No peer data available for comparison.

CapEx as Percentage of Revenue

-3.79%

No peer data available for comparison.

Weighted Average Cost of Capital (WACC)

5.07%

No peer data available for comparison.

Cost of Equity

5.18%

No peer data available for comparison.

Cost of Debt

3.99%

No peer data available for comparison.

Beta

0.25

No peer data available for comparison.

Diluted Shares Outstanding

79.24M

No peer data available for comparison.

Total Debt

34.06B

No peer data available for comparison.

Total Equity

696.60B

No peer data available for comparison.

Total Capital

730.66B

No peer data available for comparison.

Debt Weighting

4.66%

No peer data available for comparison.

Equity Weighting

95.34%

No peer data available for comparison.

EBIAT

20.51B

No peer data available for comparison.

Unlevered Free Cash Flow

90.99B

No peer data available for comparison.

Long-Term Growth Rate

2.00%

No peer data available for comparison.

Terminal Value

379.47B

No peer data available for comparison.

Enterprise Value

352.81B

No peer data available for comparison.

Net Debt

-18.24B

No peer data available for comparison.

Equity Value

371.05B

No peer data available for comparison.

Equity Value Per Share

4682.65

No peer data available for comparison.

Select Metric for Chart